Racemetyrosine

DB16306InvestigationalSmall molecule

Racemetyrosine is under investigation in clinical trial NCT03512756 (A Randomized Phase 2/3 Multi-center Study of SM-88 in Patients With Metastatic Pancreatic Cancer).

Mechanism: Pharmacologically active on Tyrosine 3-monooxygenase
Curator reviewed
Formula / weight: C₁₀H₁₃NO₃ · 195.218 g/mol (avg)
Also known as: AMPT · DL-metyrosine · Racemetirosine
Code names: SM-88 · WHO 4292

Resolves to

Compound

UNIIX88TTO174ZCAS658-48-0ChEMBLCHEMBL1330596

Structure

InChIKeyNHTGHBARYWONDQ-UHFFFAOYSA-NSMILESCC(N)(CC1=CC=C(O)C=C1)C(O)=O

Targets

P07101TH

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Racemetyrosine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account